Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can) - PubMed (original) (raw)
. 2011 Jun 1;117(11):2398-407.
doi: 10.1002/cncr.25772. Epub 2010 Dec 17.
Annekatrin Lukanova, Tone Bjørge, Hanno Ulmer, Jonas Manjer, Martin Almquist, Hans Concin, Anders Engeland, Göran Hallmans, Gabriele Nagel, Steinar Tretli, Marit B Veierød, Håkan Jonsson, Pär Stattin; Metabolic Syndrome Cancer Project Me-Can Group
Affiliations
- PMID: 24048787
- DOI: 10.1002/cncr.25772
Free article
Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the metabolic syndrome and cancer project (Me-Can)
Tanja Stocks et al. Cancer. 2011.
Free article
Abstract
Background: The metabolic syndrome (MetS) has been related to an increased risk of colorectal cancer, but the modest size of previous studies precluded detailed characterization of the role of individual MetS factors and their interaction on risk.
Methods: In the Metabolic Syndrome and Cancer Project (Me-Can), data on body mass index (BMI), blood pressure, and blood levels of glucose, cholesterol, and triglycerides were available for 578,700 men and women. The mean age of participants at baseline was 44 years, and the mean follow-up was 12 years. Relative risks (RR) of colorectal cancer per 1 standard deviation increment in Z score of factors and for a combined MetS score, were calculated from Cox regression models, including adjustment for potential confounders.
Results: During follow-up, 2834 men and 1861 women were diagnosed with colorectal cancer. The RR of colorectal cancer for the MetS score was 1.25 (95% confidence interval [CI], 1.18-1.32) in men, and 1.14 (95% CI, 1.06-1.22) in women. Significant associations also were observed in men for BMI (RR, 1.07; 95% CI, 1.02-1.13), blood pressure (RR, 1.10; 95% CI, 1.02-1.18), and triglycerides (RR, 1.17; 95% CI, 1.06-1.28) and, in women, for BMI (RR, 1.08; 95% CI, 1.01-1.15). There was no significant positive interaction between the metabolic factors on risk.
Conclusions: The combination of metabolic factors and some separate factors was related to an increased risk of colorectal cancer, but there was no interaction between metabolic factors.
Keywords: blood glucose; blood pressure; cholesterol; cohort studies; colorectal neoplasms; epidemiology; metabolic syndrome X; overweight; triglycerides.
Copyright © 2010 American Cancer Society.
Similar articles
- Metabolic risk factors and ovarian cancer in the Metabolic Syndrome and Cancer project.
Bjørge T, Lukanova A, Tretli S, Manjer J, Ulmer H, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Jonsson H, Häggström C, Stattin P, Engeland A. Bjørge T, et al. Int J Epidemiol. 2011 Dec;40(6):1667-77. doi: 10.1093/ije/dyr130. Epub 2011 Oct 7. Int J Epidemiol. 2011. PMID: 21984693 - Prospective study on metabolic factors and risk of prostate cancer.
Häggström C, Stocks T, Ulmert D, Bjørge T, Ulmer H, Hallmans G, Manjer J, Engeland A, Nagel G, Almqvist M, Selmer R, Concin H, Tretli S, Jonsson H, Stattin P. Häggström C, et al. Cancer. 2012 Dec 15;118(24):6199-206. doi: 10.1002/cncr.27677. Epub 2012 Oct 22. Cancer. 2012. PMID: 23090855 - Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project.
Bjørge T, Lukanova A, Jonsson H, Tretli S, Ulmer H, Manjer J, Stocks T, Selmer R, Nagel G, Almquist M, Concin H, Hallmans G, Häggström C, Stattin P, Engeland A. Bjørge T, et al. Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1737-45. doi: 10.1158/1055-9965.EPI-10-0230. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20615887 - The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.
Jinjuvadia R, Lohia P, Jinjuvadia C, Montoya S, Liangpunsakul S. Jinjuvadia R, et al. J Clin Gastroenterol. 2013 Jan;47(1):33-44. doi: 10.1097/MCG.0b013e3182688c15. J Clin Gastroenterol. 2013. PMID: 23090040 Free PMC article. Review. - Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.
Esposito K, Chiodini P, Capuano A, Bellastella G, Maiorino MI, Rafaniello C, Panagiotakos DB, Giugliano D. Esposito K, et al. Endocrine. 2013 Dec;44(3):634-47. doi: 10.1007/s12020-013-9939-5. Epub 2013 Apr 2. Endocrine. 2013. PMID: 23546613 Review.
Cited by
- Obesity and Colorectal Cancer: A Narrative Review.
Miranda BCJ, Tustumi F, Nakamura ET, Shimanoe VH, Kikawa D, Waisberg J. Miranda BCJ, et al. Medicina (Kaunas). 2024 Jul 27;60(8):1218. doi: 10.3390/medicina60081218. Medicina (Kaunas). 2024. PMID: 39202500 Free PMC article. Review. - Genetic prediction of the relationship between metabolic syndrome and colorectal cancer risk: a Mendelian randomization study.
Yuan C, Shu X, Hu Z, Jie Z. Yuan C, et al. Diabetol Metab Syndr. 2024 May 22;16(1):109. doi: 10.1186/s13098-024-01351-7. Diabetol Metab Syndr. 2024. PMID: 38773583 Free PMC article. - The Relationship Between Serum Lipids and the Formation of Colorectal Polyps.
Düzköylü Y, Demircioğlu MK, Kılavuz H, Sari S. Düzköylü Y, et al. Cureus. 2024 Apr 3;16(4):e57511. doi: 10.7759/cureus.57511. eCollection 2024 Apr. Cureus. 2024. PMID: 38706995 Free PMC article. - Association between Surrogate Markers of Insulin Resistance and the Incidence of Colorectal Cancer in Korea: A Nationwide Population-Based Study.
Son M, Moon SY, Koh M, Kang Y, Lee JY. Son M, et al. J Clin Med. 2024 Mar 12;13(6):1628. doi: 10.3390/jcm13061628. J Clin Med. 2024. PMID: 38541854 Free PMC article. - The Association of Low-Carbohydrate Diet and HECTD4 rs11066280 Polymorphism with Risk of Colorectal Cancer: A Case-Control Study in Korea.
Tran TT, Gunathilake M, Lee J, Oh JH, Chang HJ, Sohn DK, Shin A, Kim J. Tran TT, et al. Curr Dev Nutr. 2024 Feb 27;8(3):102127. doi: 10.1016/j.cdnut.2024.102127. eCollection 2024 Mar. Curr Dev Nutr. 2024. PMID: 38523829 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical